Aquaculture Pathophysiology

Aquaculture Pathophysiology

Volume I. Finfish Diseases

1st Edition - August 25, 2022

Write a review

  • Editors: Frederick S.B. Kibenge, Bernardo Baldisserotto, Roger Sie-Maen Chong
  • eBook ISBN: 9780128123379
  • Paperback ISBN: 9780128122112

Purchase options

Purchase options
DRM-free (PDF, EPub)
Available
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Aquaculture Pathophysiology, Volume I. Finfish Diseases is a diverse, practical reference on finfish diseases impacting aquaculture. It is intended for the veterinarian, fish health biologist or extensionist, fish pathologist and fish health diagnostician supporting the management of major and emerging infectious and non-infectious health risks for the key temperate, subtropical and tropical finfish species of commercial and fisheries importance. This volume should be read in partnership with volume 2 on shellfish diseases as the principles and approach to the diagnosis and management of aquacultured animal species are similar and typically researchers, teachers, students, diagnostic laboratory scientists, aquaculture technicians and farmers need to be competent across both finfish and shellfish health issues.

Key Features

  • A focus on the disease process of major or emerging viral, bacterial, fungal, and parasitic infections affecting aquacultured finfish species e.g. salmonids, carp, tilapia, eel, barramundi
  • A focus on important or emerging environmental, nutritional, genetic, deformity, toxicological, endocrine disruption and neoplastic diseases in finfish
  • A review of the immunology of finfish relevant to a practical understanding of disease diagnosis and management
  • An overview of laboratory diagnostic methods relevant to detection of finfish diseases
  • Concise discussion on the diverse risk factors of finfish diseases and options for their control

Readership

Researchers, teachers, students, diagnostic laboratory staff, clinical veterinarians, aquaculture disease practitioners, biologists, farmers, and all those in industry, government or academia who are interested in aquaculture, fisheries and comparative biology

Table of Contents

  • Cover image
  • Title page
  • Table of Contents
  • Copyright
  • Contributors
  • About the editors
  • Preface
  • Chapter 1. Descriptions of major farmed aquatic animal species
  • 1.1. Descriptions of the major farmed aquatic animal species
  • 1.2. Aquaculture sector: fish
  • 1.3. Aquaculture sector: crustaceans
  • 1.4. Aquaculture sector: mollusks
  • Chapter 2. An introduction to global aquaculture
  • 2.1. Background
  • 2.2. Aquaculture production
  • 2.3. Fish supply and demand
  • 2.4. Disease risks in aquaculture
  • 2.5. Climate change risks in aquaculture
  • 2.6. Outlook
  • Chapter 3. General introduction to pathophysiology of finfish, crustacea, and mollusks
  • 3.1. Introduction
  • 3.2. Finfish pathophysiology
  • 3.3. Crustacean pathophysiology
  • 3.4. Mollusk pathophysiology
  • 3.5. Summary
  • Section I. Finfish diseases
  • Chapter 4. Finfish laboratory methods
  • 4.1. Introduction
  • 4.2. Finfish necropsy
  • 4.3. Fixation and handling of tissue samples
  • 4.4. Histology
  • 4.5. Light microscopy
  • 4.6. Electron microscopy
  • Chapter 5. Finfish disease terminology
  • 5.1. Overview
  • 5.2. Finfish disease terminology
  • Chapter 6. Fish immunology
  • 6.1. Introduction
  • 6.2. Innate immunity in fish
  • 6.3. Adaptive immunity in fish
  • 6.4. Ontogenetic development of the fish immune system
  • 6.5. Immune response to pathogens/infectious diseases
  • Section II. Viral diseases
  • Chapter 7. Cardiomyopathy syndrome
  • 7.1. Overview
  • 7.2. Etiological agent
  • 7.3. Gross pathology and clinical signs
  • 7.4. Histopathology
  • 7.5. Isolation and identification of pathogen
  • 7.6. Molecular diagnostics
  • 7.7. Clinical pathology
  • 7.8. Diseases risk factors
  • 7.9. Disease control
  • 7.10. Conclusion
  • Chapter 8. Eel herpesvirus
  • 8.1. Overview
  • 8.2. Etiological agent
  • 8.3. Gross pathology and clinical signs
  • 8.4. Histopathology
  • 8.5. Disease risk factors
  • 8.6. Pathogen isolation and identification
  • 8.7. Molecular diagnostics
  • 8.8. Disease control
  • Chapter 9. Heart and skeletal muscle inflammation
  • 9.1. Overview
  • 9.2. Etiological agent
  • 9.3. Gross pathology and clinical signs
  • 9.4. Histopathology
  • 9.5. Isolation and identification of the pathogen
  • 9.6. Molecular diagnosis
  • 9.7. Clinical pathology
  • 9.8. Diseases risk factors
  • 9.9. Disease control
  • 9.10. Conclusion
  • Chapter 10. Infectious hematopoietic necrosis
  • 10.1. Overview
  • 10.2. Etiological agent
  • 10.3. Clinical signs and gross pathology
  • 10.4. Histopathology
  • 10.5. Disease risk factors
  • 10.6. Clinical pathology
  • 10.7. Pathogen isolation and identification
  • 10.8. Molecular diagnostics
  • 10.9. Disease control
  • Chapter 11. Infectious pancreatic necrosis
  • 11.1. Overview
  • 11.2. Etiological agent
  • 11.3. Clinical signs and gross pathology
  • 11.4. Histopathology
  • 11.5. Cellular apoptosis mechanism of IPNV
  • 11.6. Disease risk factors
  • 11.7. Pathogen isolation and identification
  • 11.8. Serology and molecular diagnostics
  • 11.9. Disease control
  • Chapter 12. Infectious salmon anemia
  • 12.1. Overview
  • 12.2. Etiological agent
  • 12.3. Clinical signs and gross pathology
  • 12.4. Histopathology
  • 12.5. Clinical pathology
  • 12.6. Disease risk factors
  • 12.7. Pathogen isolation
  • 12.8. Immunodiagnostics
  • 12.9. Molecular diagnostics
  • 12.10. Disease control
  • 12.11. Conclusion
  • Chapter 13. Japanese eel endothelial cell-infecting virus
  • 13.1. Overview
  • 13.2. Etiological agent
  • 13.3. Pathogen isolation and identification
  • 13.4. Clinical signs and gross pathology
  • 13.5. Histopathology
  • 13.6. Molecular diagnostics
  • 13.7. Disease control
  • Chapter 14. Koi herpesvirus disease
  • 14.1. Overview
  • 14.2. Etiological agent
  • 14.3. Clinical signs and gross pathology
  • 14.4. Histopathology
  • 14.5. Disease risk factors
  • 14.6. Clinical pathology
  • 14.7. Virus isolation and identification
  • 14.8. Molecular diagnostics
  • 14.9. Immunodiagnostics
  • 14.10. Disease control
  • Chapter 15. Lymphocystis virus disease
  • 15.1. Overview
  • 15.2. Etiological agent
  • 15.3. Clinical signs and gross pathology
  • 15.4. Histopathology
  • 15.5. Disease risk factors
  • 15.6. Immune response
  • 15.7. Pathogen isolation and identification
  • 15.8. Immunodiagnostics
  • 15.9. Molecular diagnostics
  • 15.10. Prevention and control
  • Chapter 16. Megalocytivirus in ornamental fish
  • 16.1. Overview
  • 16.2. Etiological agent
  • 16.3. Clinical signs and gross pathology
  • 16.4. Histopathology
  • 16.5. Pathogen isolation and identification
  • 16.6. Immunodiagnostics
  • 16.7. Molecular diagnostics
  • 16.8. Disease risk factors
  • 16.9. Disease control
  • Chapter 17. Salmonid alphavirus and pancreas disease
  • 17.1. Overview
  • 17.2. Etiological agents
  • 17.3. Gross pathology and clinical signs
  • 17.4. Histopathology
  • 17.5. Clinical pathology
  • 17.6. Immune responses
  • 17.7. Diagnostic tests
  • 17.8. Differential diagnosis
  • 17.9. Pathogen culture and isolation
  • 17.10. Immunodiagnostics
  • 17.11. Molecular diagnostics
  • 17.12. Disease transmission
  • 17.13. Disease control
  • 17.14. Conclusion
  • Chapter 18. Red sea bream iridoviral disease
  • 18.1. Overview
  • 18.2. Etiological agents
  • 18.3. Clinical signs and gross pathology
  • 18.4. Histopathology
  • 18.5. Disease risk factors
  • 18.6. Pathogen isolation and identification
  • 18.7. Immunodiagnostics
  • 18.8. Molecular diagnostics
  • 18.9. Disease control
  • Chapter 19. Spring viremia of carp
  • 19.1. Overview
  • 19.2. Etiological agent
  • 19.3. Clinical signs, gross pathology, and histopathology
  • 19.4. Disease risk factors
  • 19.5. Sample collection for diagnostic testing
  • 19.6. Pathogen isolation and identification
  • 19.7. Molecular diagnostics
  • 19.8. Control, treatment, and management
  • 19.9. Conclusions
  • Chapter 20. Tasmanian Atlantic salmon reovirus
  • 20.1. Overview
  • 20.2. Etiological agent
  • 20.3. Clinical signs and gross pathology
  • 20.4. Histopathological findings
  • 20.5. Disease risk factors
  • 20.6. Transmission electron microscopy
  • 20.7. Pathogen isolation
  • 20.8. Immunodiagnostic tests
  • 20.9. Molecular analysis
  • 20.10. Disease control
  • Chapter 21. Tilapia lake virus disease
  • 21.1. Overview
  • 21.2. Etiological agent
  • 21.3. Clinical signs and gross pathology
  • 21.4. Histopathology
  • 21.5. Disease risk factors
  • 21.6. Clinical pathology
  • 21.7. Virus isolation
  • 21.8. Molecular diagnostics
  • 21.9. Disease control
  • Chapter 22. Viral encephalopathy and retinopathy
  • 22.1. Overview
  • 22.2. Etiological agent
  • 22.3. Clinical signs and gross pathology
  • 22.4. Histopathology
  • 22.5. Disease risk factors
  • 22.6. Pathogen isolation and identification
  • 22.7. Molecular diagnostics
  • 22.8. Disease prevention and control
  • Chapter 23. Viral hemorrhagic septicemia virus: a review
  • 23.1. Overview
  • 23.2. Etiological agent
  • 23.3. Gross pathology and clinical signs
  • 23.4. Histopathology
  • 23.5. Clinical pathology
  • 23.6. Pathogen isolation and detection
  • 23.7. Immune responses
  • 23.8. Prevention and control
  • Section III. Bacterial diseases
  • Chapter 24. Aeromoniasis
  • 24.1. Overview
  • 24.2. Etiological agents
  • 24.3. Clinical signs, pathology, and disease risks
  • 24.4. Pathogen isolation and identification
  • 24.5. Disease control
  • Chapter 25. Bacterial kidney disease
  • 25.1. Overview
  • 25.2. Etiological agent
  • 25.3. Clinical signs and gross pathology
  • 25.4. Histopathology
  • 25.5. Disease risk factors
  • 25.6. Pathogen isolation and identification
  • 25.7. Disease control
  • Chapter 26. Edwardsiellosis
  • 26.1. Overview
  • 26.2. Etiological agent
  • 26.3. Clinical signs and gross pathology
  • 26.4. Histopathology
  • 26.5. Disease risk factors
  • 26.6. Pathogen isolation and identification
  • 26.7. Immunodiagnostics
  • 26.8. Molecular diagnostics
  • 26.9. Disease prevention and control
  • Chapter 27. Epitheliocystis
  • 27.1. Overview
  • 27.2. Etiological agents
  • 27.3. Clinical signs and gross pathology
  • 27.4. Histopathology
  • 27.5. Clinical pathology
  • 27.6. Disease risk factors
  • 27.7. Pathogen isolation and identification
  • 27.8. Molecular diagnostics
  • 27.9. Disease control
  • Chapter 28. Flavobacteriosis
  • 28.1. Overview
  • 28.2. Etiological agent
  • 28.3. Clinical signs and gross pathology
  • 28.4. Histopathology
  • 28.5. Disease risk factors
  • 28.6. Clinical pathology
  • 28.7. Pathogen isolation and identification
  • 28.8. Molecular and immunodiagnostics
  • 28.9. Disease control
  • Chapter 29. Francisellosis in tilapia and other warmwater fish
  • 29.1. Overview
  • 29.2. Etiological agent
  • 29.3. Clinical and postmortem signs
  • 29.4. Histopathology
  • 29.5. Disease risk factors
  • 29.6. Clinical pathology
  • 29.7. Pathogen isolation and identification
  • 29.8. Immunodiagnostics
  • 29.9. Molecular diagnostics
  • 29.10. Disease control
  • Chapter 30. Furunculosis
  • 30.1. Overview
  • 30.2. Etiological agent
  • 30.3. Clinical signs and gross pathology
  • 30.4. Histopathology
  • 30.5. Disease risk factors
  • 30.6. Clinical pathology
  • 30.7. Pathogen isolation and identification
  • 30.8. Immunodiagnostics
  • 30.9. Molecular diagnostics
  • 30.10. Disease control
  • Chapter 31. Mycobacteriosis
  • 31.1. Overview
  • 31.2. Etiological agents
  • 31.3. Clinical signs and gross pathology
  • 31.4. Histopathology
  • 31.5. Disease risk factors
  • 31.6. Clinical pathology
  • 31.7. Pathogen isolation and identification
  • 31.8. Molecular diagnostics
  • 31.9. Disease control
  • Chapter 32. Nocardiosis
  • 32.1. Overview
  • 32.2. Etiological agent
  • 32.3. Clinical signs and gross pathology
  • 32.4. Histopathology
  • 32.5. Molecular diagnostics
  • 32.6. Immune responses
  • 32.7. Disease treatment and control
  • Chapter 33. Pasteurellosis-photobacteriosis
  • 33.1. Overview
  • 33.2. Etiological agent
  • 33.3. Clinical signs and gross pathology
  • 33.4. Histopathology
  • 33.5. Disease risk factors
  • 33.6. Clinical pathology
  • 33.7. Pathogen isolation and identification
  • 33.8. Molecular diagnostics
  • 33.9. Disease control
  • Chapter 34. Piscirickettsia salmonis infection
  • 34.1. Overview
  • 34.2. Etiological agent
  • 34.3. Clinical signs and gross pathology
  • 34.4. Histopathology
  • 34.5. Clinical pathology
  • 34.6. Disease risk factors
  • 34.7. Pathogen isolation and identification
  • 34.8. Molecular and immunodiagnostics
  • 34.9. Disease control
  • Chapter 35. Streptococcosis
  • 35.1. Overview
  • 35.2. Etiological agent
  • 35.3. Clinical signs and gross pathology
  • 35.4. Histopathology
  • 35.5. Molecular diagnostics
  • 35.6. Immune responses
  • 35.7. Diseases treatment and control
  • Chapter 36. Vibriosis
  • 36.1. Overview
  • 36.2. Etiological agent
  • 36.3. Clinical signs and gross pathology
  • 36.4. Histopathology
  • 36.5. Disease risk factors
  • 36.6. Clinical pathology
  • 36.7. Pathogen isolation and identification
  • 36.8. Immunodiagnostics
  • 36.9. Molecular diagnostics
  • 36.10. Disease control
  • Section IV. Parasitic diseases
  • Chapter 37. Amoebic gill disease
  • 37.1. Overview
  • 37.2. Etiological agent
  • 37.3. Clinical signs and gross pathology
  • 37.4. Histopathology
  • 37.5. Clinical pathology
  • 37.6. Disease risk factors
  • 37.7. Pathogen isolation and identification
  • 37.8. Molecular diagnostics
  • 37.9. Disease control
  • Chapter 38. Amyloodiniosis
  • 38.1. Overview
  • 38.2. Etiological agent
  • 38.3. Clinical signs and gross pathology
  • 38.4. Histopathology
  • 38.5. Disease risk factors
  • 38.6. Pathogen isolation and identification
  • 38.7. Molecular diagnostics
  • 38.8. Disease control
  • Chapter 39. Chilodonella and Brooklynella infections
  • 39.1. Overview
  • 39.2. Etiological agents
  • 39.3. Clinical signs and gross pathology
  • 39.4. Histopathology
  • 39.5. Disease risk factors
  • 39.6. Clinical pathology
  • 39.7. Pathogen isolation and identification
  • 39.8. Molecular diagnostics
  • 39.9. Disease control
  • Chapter 40. Infection by Ichthyophthirius multifiliis
  • 40.1. Overview
  • 40.2. Etiological agent
  • 40.3. Clinical signs and gross pathology
  • 40.4. Histopathology and immune response
  • 40.5. Clinical pathology
  • 40.6. Disease risk factors
  • 40.7. Pathogen isolation and identification
  • 40.8. Disease control
  • Chapter 41. Cryptocaryon irritans infection
  • 41.1. Overview
  • 41.2. Etiological agent systematics
  • 41.3. Host range and specificity
  • 41.4. Tolerance ranges
  • 41.5. Life cycle and morphology
  • 41.6. Host transmission
  • 41.7. Clinical signs and diagnosis
  • 41.8. Histopathology
  • 41.9. Treatment and control
  • Chapter 42. Infection with Gyrodactylus salaris
  • 42.1. Overview
  • 42.2. Etiological agent
  • 42.3. Clinical signs and gross pathology
  • 42.4. Histopathology
  • 42.5. Virulence factors
  • 42.6. Clinical pathology
  • 42.7. Parasite identification
  • 42.8. Molecular diagnostics
  • 42.9. Disease control
  • Chapter 43. Monogenean infections
  • 43.1. Overview
  • 43.2. Etiological agent
  • 43.3. Clinical signs, gross and histopathology
  • 43.4. Disease risk factors
  • 43.5. Clinical pathology
  • 43.6. Pathogen isolation and identification
  • 43.7. Molecular diagnostics
  • 43.8. Disease control
  • Chapter 44. Myxozoan infections
  • 44.1. Overview
  • 44.2. Etiological agents
  • 44.3. Clinical signs and gross pathology
  • 44.4. Histopathology
  • 44.5. Clinical pathology
  • 44.6. Disease risk factors
  • 44.7. Pathogen isolation and identification
  • 44.8. Molecular and immunodiagnostics
  • 44.9. Disease control
  • Chapter 45. Sea lice
  • 45.1. Overview
  • 45.2. Etiological agents
  • 45.3. Clinical signs and gross pathology
  • 45.4. Histopathology
  • 45.5. Disease risk factors
  • 45.6. Clinical pathology
  • 45.7. Pathogen isolation and identification
  • 45.8. Molecular diagnostics
  • 45.9. Disease control
  • Chapter 46. Digenetic trematode infections
  • 46.1. Overview
  • 46.2. Etiological agents
  • 46.3. Clinical signs, gross pathology, histopathology, and clinical pathology
  • 46.4. Disease risk factors
  • 46.5. Pathogen isolation and identification
  • 46.6. Molecular diagnostics
  • 46.7. Disease control
  • Chapter 47. Tetrahymenosis and scuticociliatosis
  • 47.1. Overview
  • 47.2. Etiological agents
  • 47.3. Clinical signs and gross pathology
  • 47.4. Histopathology
  • 47.5. Disease risk factors
  • 47.6. Clinical pathology
  • 47.7. Pathogen isolation and identification
  • 47.8. Molecular diagnostics
  • 47.9. Disease control
  • Chapter 48. Trypanosomiasis
  • 48.1. Overview
  • 48.2. Etiological agents
  • 48.3. Clinical signs and gross pathology
  • 48.4. Histopathology
  • 48.5. Clinical pathology
  • 48.6. Disease risk factors
  • 48.7. Pathogen isolation and identification
  • 48.8. Molecular diagnostics
  • 48.9. Disease control
  • Chapter 49. Whirling disease
  • 49.1. Overview
  • 49.2. Etiological agent and life cycle
  • 49.3. Clinical signs and gross pathology
  • 49.4. Histopathology
  • 49.5. Disease risk factors
  • 49.6. Pathogen isolation and identification
  • 49.7. Molecular diagnostics
  • 49.8. Disease control
  • Section V. Fungal diseases
  • Chapter 50. Epizootic ulcerative syndrome
  • 50.1. Overview
  • 50.2. Etiological agent
  • 50.3. Clinical signs and gross pathology
  • 50.4. Histopathology
  • 50.5. Disease risk factors
  • 50.6. Clinical pathology
  • 50.7. Pathogen isolation and identification
  • 50.8. Immunodiagnostics
  • 50.9. Molecular diagnostics
  • 50.10. Disease control
  • Chapter 51. Ichthyophoniasis
  • 51.1. Overview
  • 51.2. Etiological agent
  • 51.3. Clinical signs and gross pathology
  • 51.4. Histopathology
  • 51.5. Disease risk factors
  • 51.6. Clinical pathology
  • 51.7. Pathogen isolation and identification
  • 51.8. Molecular diagnostics
  • 51.9. Disease control
  • Chapter 52. Microsporidian infections
  • 52.1. Overview
  • 52.2. Etiological agent
  • 52.3. Clinical signs and gross pathology
  • 52.4. Histopathology
  • 52.5. Disease risk factors
  • 52.6. Pathogen isolation and identification
  • 52.7. Molecular diagnostics
  • 52.8. Disease control
  • Chapter 53. Saprolegniasis
  • 53.1. Overview
  • 53.2. Etiological agent
  • 53.3. Clinical signs and gross pathology
  • 53.4. Histopathology
  • 53.5. Disease risk factors
  • 53.6. Clinical pathology
  • 53.7. Pathogen isolation and identification
  • 53.8. Immunodiagnostics
  • 53.9. Molecular diagnostics
  • 53.10. Disease control
  • Section VI. Nutritional diseases
  • Chapter 54. Amino acid deficiency and toxicity
  • 54.1. Overview
  • 54.2. Etiology
  • 54.3. Clinical signs, gross pathology, and histopathology
  • 54.4. Disease risk factors
  • 54.5. Disease control
  • Chapter 55. Antinutritional factors in plant-based feeds
  • 55.1. Overview
  • 55.2. Etiological agents and pathogenesis
  • 55.3. Clinical signs and gross pathology
  • 55.4. Histopathology
  • 55.5. Disease risk factors
  • 55.6. Clinical pathology
  • 55.7. Disease control
  • Chapter 56. Fatty acid deficiency, fatty liver, liver lipoid disease, and toxic non-essential fatty acid
  • 56.1. Overview
  • 56.2. Etiology
  • 56.3. Clinical signs, gross pathology, and histopathology
  • 56.4. Disease risk factors
  • 56.5. Laboratory diagnosis
  • 56.6. Disease control
  • Chapter 57. Fungal toxins in feedstuffs
  • 57.1. Overview
  • 57.2. Etiological agents and pathogenesis
  • 57.3. Disease risk factors
  • 57.4. Laboratory testing
  • 57.5. Disease control
  • Chapter 58. Investigating ill thrift in yellowtail kingfish Seriola lalandi
  • 58.1. Overview
  • 58.2. Characterization of the bacterial pathogens
  • 58.3. Gross pathology and clinical signs
  • 58.4. Histopathology
  • 58.5. Clinical pathology
  • 58.6. Pathogenesis
  • Chapter 59. Mineral deficiency and toxicity
  • 59.1. Overview
  • 59.2. Clinical signs, pathology, and pathogenesis
  • 59.3. Disease risk factors
  • 59.4. Disease control
  • Chapter 60. Vitamin deficiency and toxicity
  • 60.1. Overview
  • 60.2. Clinical signs, gross pathology, and histopathology
  • 60.3. Disease risk factors
  • 60.4. Disease control
  • Section VII. Environmental diseases
  • Chapter 61. Ammonia toxicosis
  • 61.1. Overview
  • 61.2. Etiological process
  • 61.3. Clinical signs and gross pathology
  • 61.4. Histopathology
  • 61.5. Clinical pathology
  • 61.6. Disease risk factors
  • 61.7. Disease control
  • Chapter 62. Carbon dioxide toxicosis
  • 62.1. Overview
  • 62.2. Etiological process
  • 62.3. Clinical signs and gross pathology
  • 62.4. Histopathology
  • 62.5. Clinical pathology
  • 62.6. Disease risk factors
  • 62.7. Laboratory tests
  • 62.8. Disease control
  • Chapter 63. Chlorine toxicosis
  • 63.1. Overview
  • 63.2. Etiological process
  • 63.3. Clinical signs and gross pathology
  • 63.4. Histopathology
  • 63.5. Disease risk factors
  • 63.6. Laboratory tests
  • 63.7. Disease control
  • Chapter 64. Chronic diseases of the lateral line organ in fish
  • 64.1. Overview
  • 64.2. Chronic ulcerative dermatopathy
  • 64.3. Lateral line depigmentation in fish
  • Chapter 65. Endocrine disruption in fish
  • 65.1. Overview
  • 65.2. Etiological processes and clinical pathology
  • 65.3. Clinical signs and gross pathology
  • 65.4. Histopathology
  • 65.5. Disease risk factors
  • 65.6. Laboratory tests
  • 65.7. Disease control
  • Chapter 66. Gas bubble disease
  • 66.1. Overview
  • 66.2. Etiological process
  • 66.3. Clinical signs and gross pathology
  • 66.4. Histopathology
  • 66.5. Clinical pathology
  • 66.6. Disease risk factors
  • 66.7. Disease control
  • Chapter 67. Harmful algal blooms
  • 67.1. Overview
  • 67.2. Etiological agents and pathogenesis
  • 67.3. Clinical signs and gross pathology
  • 67.4. Histopathology
  • 67.5. Disease risk factors
  • 67.6. Clinical pathology
  • 67.7. Laboratory diagnosis
  • 67.8. Disease control
  • Chapter 68. Hypoxia
  • 68.1. Overview
  • 68.2. Etiology
  • 68.3. Clinical signs and gross pathology
  • 68.4. Diagnosis
  • 68.5. Disease risk factors
  • 68.6. Disease control
  • Chapter 69. Metals toxicosis
  • 69.1. Overview
  • 69.2. Etiological agents and disease risk factors
  • 69.3. Clinical signs, gross, clinical, and histopathology
  • 69.4. Diagnosis
  • 69.5. Disease control
  • Chapter 70. Nitrite–nitrate toxicosis
  • 70.1. Overview
  • 70.2. Etiological process
  • 70.3. Clinical signs and gross pathology
  • 70.4. Histopathology
  • 70.5. Disease risk factors
  • 70.6. Clinical pathology
  • 70.7. Laboratory tests
  • 70.8. Disease control
  • Chapter 71. Pesticides toxicosis
  • 71.1. Overview
  • 71.2. Etiological agents
  • 71.3. Clinical signs, gross pathology, clinical pathology, and histopathology
  • 71.4. Disease risk factors
  • 71.5. Diagnostic process
  • 71.6. Disease control
  • Section VIII. Genetic and neoplastic diseases
  • Chapter 72. Fish genetic malformations
  • 72.1. Overview
  • 72.2. Pathogenesis
  • 72.3. Clinical signs and gross pathology
  • 72.4. Disease risk factors
  • 72.5. Disease control
  • Chapter 73. Aflatoxicosis
  • 73.1. Overview
  • 73.2. Etiological agent and carcinogenesis
  • 73.3. Clinical signs and gross pathology
  • 73.4. Histopathology
  • 73.5. Disease risk factors
  • 73.6. Laboratory diagnosis
  • 73.7. Disease control
  • Chapter 74. Chemical carcinogenic diseases
  • 74.1. Overview
  • 74.2. Etiological agents and carcinogenesis
  • 74.3. Clinical signs, gross pathology and histopathology
  • 74.4. Disease risk factors
  • 74.5. Disease control
  • Chapter 75. Classification of fish neoplasia
  • 75.1. Overview
  • 75.2. Neoplasia classification
  • 75.3. Clinical signs, gross pathology, and histopathology
  • 75.4. Disease risk factors
  • 75.5. Disease control
  • Chapter 76. Oncogenic finfish viral diseases
  • 76.1. Overview
  • 76.2. Etiological agents
  • 76.3. Clinical signs and gross pathology
  • 76.4. Histopathology
  • 76.5. Disease risk factors
  • 76.6. Clinical pathology
  • 76.7. Pathogen isolation and identification
  • 76.8. Molecular diagnostics
  • 76.9. Disease control
  • Index

Product details

  • No. of pages: 876
  • Language: English
  • Copyright: © Academic Press 2022
  • Published: August 25, 2022
  • Imprint: Academic Press
  • eBook ISBN: 9780128123379
  • Paperback ISBN: 9780128122112

About the Editors

Frederick S.B. Kibenge

Dr. Frederick Kibenge is Professor of Virology at the Atlantic Veterinary College, University of Prince Edward Island. He obtained his BVM from Makerere University and his PhD from Murdoch University, and he is the former Chairman of the Department of Pathology and Microbiology at the Atlantic Veterinary College. Dr. Kibenge has more than 30 years of experience investigating animal viruses and the biology of viral pathogens. His research focuses on understanding the mechanisms of virus virulence to improve on methods of virus detection and control.

Affiliations and Expertise

Professor of Virology, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PEI, Canada

Bernardo Baldisserotto

Bernardo Baldisserotto is a full professor in the Department of Physiology and Pharmacology at the Federal University of Santa Maria. He has published five books on fish physiology and fish culture, and has organized and participated in numerous other books and journal publications. Dr. Baldisserotto is editor-in-chief for the Physiology and Biochemistry section of Neotropical Ichthyology and associate editor of Fishes and the Journal of the World Aquaculture Society.

Affiliations and Expertise

Full Professor, Department of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil

Roger Sie-Maen Chong

Dr. Roger Sie-Maen CHONG is a veterinary specialist in Australia and the United Kingdom (UK), with expertise in fish and shellfish pathology as applied to the health and biosecurity of aquacultured species. He is officially registered as a specialist by the Queensland Board of Veterinary Surgeons for Veterinary Aquatic Animal Health (Australia) and by the Royal College of Veterinary Surgeons for Fish Health and Production (UK). He is also a certified Fish Pathologist recognized by the Fish Health Section of the American Fisheries Society. Dr. Chong has worked in Hong Kong with the Department of Agriculture, Fisheries & Conservation, in Queensland with the Biosecurity Queensland and is presently a research fish pathologist with the Australian Commonwealth Scientific and Industrial Research Organization (CSIRO).

Affiliations and Expertise

Registered Veterinary Specialist of Fish Health and Production, Royal College of Veterinary Surgeons, UK; Registered Specialist of Veterinary Aquatic Animal Health, Queensland Veterinary Surgeons Board; Australia Veterinary Aquatic Pathologist, Commonwealth Scientific and Industrial Research Organization (CSIRO), Australia

Ratings and Reviews

Write a review

There are currently no reviews for "Aquaculture Pathophysiology"